Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diana Incekol"'
Publikováno v:
Canadian Oncology Nursing Journal, Vol 29, Iss 4, Pp 247-252 (2019)
Le cancer est l’une des principales causes de décès et d’invalidité dans le monde. Les infirmières doivent donc prodiguer des soins spécialisés à un nombre croissant de patients avec des cas de cancer complexes. Toutefois, de nombreux éta
Externí odkaz:
https://doaj.org/article/c691d927752f4d55b7e2c7f9c04af0a0
Redesigning and implementing a Canadian oncology nursing curriculum for an international partnership
Publikováno v:
Canadian Oncology Nursing Journal, Vol 29, Iss 4, Pp 242-246 (2019)
Cancer is one of the leading causes of death and disability globally. As a result, there is a need to provide specialized nursing care to the increasing number of complex oncology patients. Numerous healthcare centres do not have specialized oncology
Externí odkaz:
https://doaj.org/article/bbe70e907f1a44d5832bf3d9d25de62d
Publikováno v:
Clinical journal of oncology nursing. 20(1)
As part of a comprehensive orientation for nurses caring for patients with hematologic malignancies, nurses are expected to attend general corporate orientation immediately followed by hospital site-specific nursing orientation. The orientation is co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571e13af269248328493929df48273a2
https://pubmed.ncbi.nlm.nih.gov/26800414
https://pubmed.ncbi.nlm.nih.gov/26800414
Autor:
Cindy Murray, Emma Paisley, Diana Incekol, Karen W.L. Yee, Roy Lee, Lauren F Ferruccio, Pamela Ng
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 22(4)
The azacitidine (Vidaza®) product monograph indicates that doses greater than 4 ml should be divided equally into two syringes and injected into different sites. Although 2 ml is a more commonly used maximum volume for subcutaneous injections, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e63513b3ee7cc8fef5eb1ffceafd19
https://pubmed.ncbi.nlm.nih.gov/26248754
https://pubmed.ncbi.nlm.nih.gov/26248754
Autor:
Diana Incekol, Marina Kaufman, Dominic Tsang, Rita Kwong, Emma Paisley, Ian Brandle, Vishal Kukreti, Jack T Seki, Roy E Lee, Monika K. Krzyzanowska
Publikováno v:
Journal of Clinical Oncology. 30:314-314
314 Background: History of hypersensitivity reactions (HSR) must be readily accessible to ensure patient safety while receiving chemotherapy. While documentation of HSR is a routine process, gaps are found in maintaining vital information amongst var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81fe94dc2cc2fc9551d582d9d87a31ca
https://doi.org/10.1200/jco.2012.30.34_suppl.314
https://doi.org/10.1200/jco.2012.30.34_suppl.314